Drug Profile
TD 1414
Alternative Names: TD-1414Latest Information Update: 27 Nov 2009
Price :
$50
*
At a glance
- Originator LEO Pharma
- Class Antibacterials
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Skin and soft tissue infections